Takeo Yoshikawa

3.2k total citations
86 papers, 1.9k citations indexed

About

Takeo Yoshikawa is a scholar working on Immunology, Molecular Biology and Sensory Systems. According to data from OpenAlex, Takeo Yoshikawa has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 34 papers in Molecular Biology and 22 papers in Sensory Systems. Recurrent topics in Takeo Yoshikawa's work include Mast cells and histamine (26 papers), Olfactory and Sensory Function Studies (21 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Takeo Yoshikawa is often cited by papers focused on Mast cells and histamine (26 papers), Olfactory and Sensory Function Studies (21 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Takeo Yoshikawa collaborates with scholars based in Japan, United States and China. Takeo Yoshikawa's co-authors include Kazuhiko Yanai, Tadaho Nakamura, Ryuichi Harada, Nobuyuki Okamura, Fumito Naganuma, Tomomitsu Iida, Shozo Furumoto, Yukitsuka Kudo, Ren Iwata and Attayeb Mohsen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and NeuroImage.

In The Last Decade

Takeo Yoshikawa

86 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeo Yoshikawa Japan 26 686 579 413 273 228 86 1.9k
Atsuko Inoue Japan 25 782 1.1× 539 0.9× 206 0.5× 544 2.0× 143 0.6× 86 2.3k
Derya R. Shimshek Switzerland 30 1.0k 1.5× 949 1.6× 180 0.4× 924 3.4× 214 0.9× 54 3.0k
Hyun B. Choi Canada 33 1.4k 2.1× 755 1.3× 583 1.4× 1.4k 5.1× 127 0.6× 45 4.4k
John G. J. M. Bol Netherlands 29 554 0.8× 495 0.9× 244 0.6× 668 2.4× 94 0.4× 67 2.2k
Georgia Mandolesi Italy 37 937 1.4× 296 0.5× 388 0.9× 1.1k 4.0× 112 0.5× 81 3.4k
Diederik Moechars Belgium 28 1.3k 1.8× 1.9k 3.2× 353 0.9× 1.1k 4.1× 121 0.5× 53 3.8k
Ann Massie Belgium 28 1.2k 1.8× 346 0.6× 239 0.6× 1.2k 4.2× 92 0.4× 87 3.2k
Lasse Dissing‐Olesen Canada 19 1.1k 1.5× 655 1.1× 1.3k 3.2× 995 3.6× 88 0.4× 22 4.2k
Eiichiro Nagata Japan 30 2.1k 3.1× 588 1.0× 222 0.5× 1.2k 4.5× 118 0.5× 117 4.0k
Hortensia Alonso‐Navarro Spain 29 510 0.7× 295 0.5× 142 0.3× 552 2.0× 40 0.2× 148 2.6k

Countries citing papers authored by Takeo Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Takeo Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Yoshikawa more than expected).

Fields of papers citing papers by Takeo Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Yoshikawa. The network helps show where Takeo Yoshikawa may publish in the future.

Co-authorship network of co-authors of Takeo Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Yoshikawa. A scholar is included among the top collaborators of Takeo Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Yoshikawa. Takeo Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2023). Epitope Mapping of the Novel Anti-Human CCR9 Monoclonal Antibody (C 9 Mab-11) by 2 × Alanine Scanning. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(2). 73–76. 2 indexed citations
2.
Asano, Teizo, Tomohiro Tanaka, Yuki Okada, et al.. (2023). Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies (C 3 Mab-6 and C 3 Mab-7). Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(2). 68–72. 1 indexed citations
3.
Li, Guanjie, Hiroyuki Suzuki, Tomohiro Tanaka, et al.. (2023). Epitope Mapping of an Anti-EpCAM Monoclonal Antibody (EpMab-37) Using the Alanine Scanning Method. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 41–47. 1 indexed citations
4.
Li, Guanjie, Hiroyuki Suzuki, Tomokazu Ohishi, et al.. (2023). Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models. International Journal of Molecular Medicine. 51(2). 20 indexed citations
5.
Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Epitope Mapping of an Anti-Mouse CXCR6 Monoclonal Antibody (Cx 6 Mab-1) Using the 2 × Alanine Scanning Method. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(5). 275–278. 8 indexed citations
6.
Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Epitope Mapping Using the Cell-Based 2 × Alanine Substitution Method About the Anti-mouse CXCR6 Monoclonal Antibody, Cx 6 Mab-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 22–26. 3 indexed citations
7.
Asano, Teizo, Hiroyuki Suzuki, Tomohiro Tanaka, et al.. (2022). Establishment of a Sensitive Monoclonal Antibody Against Mouse CCR9 (C 9 Mab-24) for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 15–21. 4 indexed citations
8.
Asano, Teizo, Tomohiro Tanaka, Hiroyuki Suzuki, et al.. (2022). Development of a Novel Anti-Mouse CCR6 Monoclonal Antibody (C 6 Mab-13) by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 343–349. 2 indexed citations
9.
Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C 9 Mab-11) by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 303–310. 3 indexed citations
10.
Suzuki, Hiroyuki, Teizo Asano, Tomokazu Ohishi, et al.. (2022). Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf). Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 34–40. 1 indexed citations
11.
Saito, Masaki, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(5). 279–284. 1 indexed citations
12.
Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Epitope Mapping of an Anti-Mouse CCR2 Monoclonal Antibody (C 2 Mab-6) Using Enzyme-Linked Immunosorbent Assay. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 339–342. 1 indexed citations
13.
Nanamiya, Ren, Tomokazu Ohishi, Hiroyuki Suzuki, et al.. (2022). Defucosylated Mouse-Dog Chimeric Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H77Bf) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 27–33. 1 indexed citations
14.
Matsuzawa, Takuro, Masanobu Morita, Mei Yu, et al.. (2021). Heparan sulfate promotes differentiation of white adipocytes to maintain insulin sensitivity and glucose homeostasis. Journal of Biological Chemistry. 297(3). 101006–101006. 10 indexed citations
15.
Matsuzawa, Takuro, et al.. (2020). Heparan sulfate controls skeletal muscle differentiation and motor functions. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(12). 129707–129707. 6 indexed citations
16.
Matsuda, Ken, Akira Uruno, Kaori Sugawara, et al.. (2013). Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells. Molecular and Cellular Endocrinology. 383(1-2). 60–68. 8 indexed citations
17.
Harada, Ryuichi, Nobuyuki Okamura, Shozo Furumoto, et al.. (2013). Comparison of the Binding Properties of Tau PET Radiotracer 18F-THK523 and Other Amyloid PET Tracers to Alzheimer's Disease Pathology. 2012. 132–135. 1 indexed citations
18.
Nakamura, Tadaho, Takeo Yoshikawa, Naoya Noguchi, et al.. (2013). The expression and function of histamineH3receptors in pancreatic beta cells. British Journal of Pharmacology. 171(1). 171–185. 22 indexed citations
19.
Okamura, Nobuyuki, Masanori Mori, Shozo Furumoto, et al.. (2011). In vivo Detection of Amyloid Plaques in the Mouse Brain using the Near-Infrared Fluorescence Probe THK-265. Journal of Alzheimer s Disease. 23(1). 37–48. 52 indexed citations
20.
Xu, Ajing, Eiko Sakurai, Atsuo Kuramasu, et al.. (2010). Roles of Hypothalamic Subgroup Histamine and Orexin Neurons on Behavioral Responses to Sleep Deprivation Induced by the Treadmill Method in Adolescent Rats. Journal of Pharmacological Sciences. 114(4). 444–453. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026